Study: hypofractionated whole breast irradiation for patients with large breasts: comparing prone and supine positions
The university hospital in Gent, Belgium has compared the acute toxicity of whole breast irradiation in both the supine and the prone position (Mulliez T et al. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol (2013)). The test was performed on 100 patients. All the patients in the prone position were treated on the Orfit AIO Prone Breast Solution that was especially modified for them. Cushions have been added to the AIO Prone Breast solution to place the patient in a tilted position so that the ipsi-lateral breast falls deeper into the cut-out. A unilateral breast holder was used to pull the contra-lateral breast away from the treatment field.
The study has proven that whole breast irradiation in the prone position on the AIO Solution gives improved results. The prone treatment results in:
Improved dose coverage
Created better homogeneity
Had less volumes of over-dosage
Reduced acute skin desquamation
Had a lower incidence of dermatitis, edema, pruritus and pain
Patient set-up devices for prone CT-simulation and treatment: (A) Unilateral Unilateral breast holder to retract the contra-lateral breast away from the treated breast. (B) Prone breast board: 1: hand grip; 2: head rest; 3: carbon ﬁber wedge support of the contra-lateral breast; 4: numeric scale (at both sides of the caudal part) to adjust table height using the in-room laser system; 5: safety belt. (C) Ipsilateral (left panel) and contralateral (right panel) views of a patient positioned on the breast board.
The abstract of the clinical article can be found here.
We've selected some similar articles for you
AIO Solution 3.0 Compatible for Use with Varian Medical Systems Halcyon™ and Ethos™ Radiotherapy Systems
As part of the Varian Interoperability Program, Orfit is pleased to announce today that its AIO Solution 3.0 is compatible for use with Halcyon™ and Ethos™ radiotherapy systems.
Sagittilt: Orfit’s highly reproducible, patient friendly and heart-sparing prone breast solution
Breast cancer radiotherapy might involve some radiation exposure of the normal tissues within the thorax, including the heart and lungs. This is associated with secondary lung cancer and mortality and morbidity rates for women with left-sided breast cancer due to ischemic heart disease . Darby et al demonstrated that for…